These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37018978)

  • 21. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages.
    Liu W; Bai F; Wang H; Liang Y; Du X; Liu C; Cai D; Peng J; Zhong G; Liang X; Ma C; Gao L
    J Immunol; 2019 Aug; 203(4):990-1000. PubMed ID: 31263038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release.
    Pan J; Ou Z; Cai C; Li P; Gong J; Ruan XZ; He K
    Cell Immunol; 2018 Oct; 332():111-120. PubMed ID: 30103942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [n-3 Polyunsaturated fatty acid attenuates hyperhomocysteinemia-induced hepatic steatosis by increasing hepatic LXA
    Song H; Duan JJ; Li K; Yao L; Zhu Y
    Sheng Li Xue Bao; 2021 Aug; 73(4):551-558. PubMed ID: 34405211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7.
    Zuo R; Ye LF; Huang Y; Song ZQ; Wang L; Zhi H; Zhang MY; Li JY; Zhu L; Xiao WJ; Shang HC; Zhang Y; He RR; Chen Y
    J Nanobiotechnology; 2021 Nov; 19(1):396. PubMed ID: 34838052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
    Ruan S; Han C; Sheng Y; Wang J; Zhou X; Guan Q; Li W; Zhang C; Yang Y
    Int Immunopharmacol; 2021 Nov; 100():108126. PubMed ID: 34492534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
    Yang G; Lee HE; Lee JY
    Sci Rep; 2016 Apr; 6():24399. PubMed ID: 27075683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
    Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed Mice.
    Ai Y; Sun Z; Peng C; Liu L; Xiao X; Li J
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28368295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ.
    Chen Y; He X; Yuan X; Hong J; Bhat O; Li G; Li PL; Guo J
    Oxid Med Cell Longev; 2018; 2018():2901871. PubMed ID: 30140364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90.
    Ma J; Li M; Yang T; Deng Y; Ding Y; Guo T; Shang J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
    Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
    Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AS3MT facilitates NLRP3 inflammasome activation by m
    Qiu T; Wu C; Yao X; Han Q; Wang N; Yuan W; Zhang J; Shi Y; Jiang L; Liu X; Yang G; Sun X
    Cell Biol Toxicol; 2023 Oct; 39(5):2165-2181. PubMed ID: 35226250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
    Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
    Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protective effect of heat shock transcription factor 1 on acute lung injury in septic rats by regulating NOD-like receptor protein 3 inflammasome activation].
    Jin C; Zhang W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1167-1172. PubMed ID: 36567560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia.
    Huang D; Li G; Zhang Q; Bhat OM; Zou Y; Ritter JK; Li PL
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166146. PubMed ID: 33862145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage inflammasome mediates hyperhomocysteinemia-aggravated abdominal aortic aneurysm.
    Sun W; Pang Y; Liu Z; Sun L; Liu B; Xu M; Dong Y; Feng J; Jiang C; Kong W; Wang X
    J Mol Cell Cardiol; 2015 Apr; 81():96-106. PubMed ID: 25680906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRP3 inflammasome blocked the glycolytic pathway via targeting to PKLR in arsenic-induced hepatic insulin resistance.
    Zhang J; Qiu T; Jiang L; Wang N; Zhu Y; Yan R; Wang S; Bai J; Shi X; Yang G; Liu X; Yao X; Sun X
    Ecotoxicol Environ Saf; 2021 Oct; 223():112590. PubMed ID: 34364127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.